Clinical Trials Sponsored by Linyi Cancer Hospital

Total 9846 results

Children's Hospital Medical Center, Cincinnati
Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center

Recruiting

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

Fanconi Anemia | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Severe Marrow Failure

United States
Fudan University
Zhejiang Cancer Hospital; Huashan Hospital; Henan Cancer Hospital; Hunan Cancer... and other collaborators

Not yet recruiting

Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction (CAPPELLA)

Breast Cancer

China
Jinan Military General Hospital
Guangzhou First People's Hospital; Shengjing Hospital; Qingdao University; Institute... and other collaborators

Unknown

ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia

Aplastic Anemia

China
Invitae Corporation
National Cancer Center Hospital East

Recruiting

Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel (ARTEMIS-PC)

Pancreatic Cancer

Japan
German Cancer Research Center
University Hospital Heidelberg

Recruiting

A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients With Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma (IntenSify)

Pancreatic Cancer | Pancreatic Adenocarcinoma | CYP3A Inhibitor | Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma | Pancreatic Neoplasm

Germany
Indonesia University
Dharmais National Cancer Center Hospital

Recruiting

Vitamin D and Pre Cachexia and Cancer Cachexia in Epithelial Ovarian Cancer (VitD)

Epithelial Ovarian Cancer

Indonesia
M.D. Anderson Cancer Center
Massachusetts General Hospital

Completed

Early Detection and Prediction of Chemotherapy Induced Cardiac Toxicity in Breast Cancer Patients

Breast Cancer

United States
Samsung Medical Center
National Cancer Center, Korea; Asan Medical Center; Yonsei University; Korea Cancer...

Completed

RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas (RADCHOP)

Cutaneous T Cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-negative | Angioimmunoblastic T Cell Lymphoma | Peripheral T Cell Lymphoma Unspecified

Korea, Republic of
German Cancer Research Center
University Hospital Heidelberg

Recruiting

CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer (CATCH)

Metastatic Breast Cancer

Germany
University Hospital Heidelberg
German Cancer Research Center

Recruiting

INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies (INFORM2 NivEnt)

Solid Tumor | CNS Tumor

France, Germany, Australia, Austria, Sweden, Netherlands, Switzerland
German Cancer Research Center
University Hospital Heidelberg

Active, not recruiting

Exercise Interventions for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy (BENEFIT)

Breast Cancer

Germany
German Cancer Research Center
University Hospital Heidelberg

Completed

Nutrition and Energy Restriction for Cancer Prevention (HELENA)

Metabolic Diseases | Obesity | Weight Loss | Body Composition, Beneficial | Visceral Obesity

Germany
German Cancer Research Center
University Hospital Heidelberg

Withdrawn

Longitudinal Investigation of Cancer-related Fatigue (LIFT)

Cancer-related Fatigue
Trisakti University
Dharmais National Cancer Center Hospital

Unknown

Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen

Breast Cancer Female

Indonesia
University Hospital Heidelberg
German Cancer Research Center

Completed

Mitochondrial Effects of C18:0 Supplementation in Humans

Type2 Diabetes | Fatty Acid Deficiency | Alteration of Mitochondrial Membrane

Germany
National Cancer Center, Korea
Asan Medical Center; Severance Hospital

Unknown

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)

Hodgkin's Lymphoma

Korea, Republic of
University Hospital Heidelberg
German Cancer Research Center

Recruiting

Systematic Evaluation of Human Explant Model Systems Engineering (SEEDLING)

Solid Tumor, Adult

Germany
University Hospital Tuebingen
German Cancer Research Center

Recruiting

the Bispecific PSMAxCD3 Antibody CC-1 in Patients With Castration Resistant Prostate Carcinoma (PSMAxCD3)

Castration-Resistant Prostatic Cancer

Germany
University Hospital Heidelberg
German Cancer Research Center

Completed

Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

Colorectal Cancer Metastatic | Pancreatic Cancer Metastatic

Germany
German Cancer Research Center
University Hospital Tuebingen

Terminated

Bispecific PSMAxCD3 Antibody CC-1 in Patients With Squamous Cell Carcinoma of the Lung

Lung Cancer Squamous Cell

Germany
German Cancer Research Center
University Hospital Heidelberg

Completed

Systematic and Mechanism-based Approach to Rational Treatment Trials of Blood Cancer (SMART)

Hematologic Diseases | Treatment

Germany
University Hospital Heidelberg
German Cancer Research Center

Completed

Trial of Neoadjuvant Intensity-Modulated Radiation Therapy Followed by Surgery and Intraoperative Radiation Therapy in Resectable Retroperitoneal Soft Tissue Sarcoma (RETRO-WTS)

Retroperitoneal Soft Tissue Sarcoma

Germany
Seattle Children's Hospital
Fred Hutchinson Cancer Center

Completed

Improving Physical Activity in Young Adult Cancer Survivors

Quality of Life | Physical Activity

United States
Incheon St.Mary's Hospital
National Cancer Center, Korea

Unknown

Procarbazine and Lomustine in Recurrent Glioblastoma

Recurrent Glioblastoma Multiforme

Korea, Republic of
University Hospital Heidelberg
German Cancer Research Center

Unknown

Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer (NEOPANC)

Pancreatic Neoplasms

Germany
Hepatopancreatobiliary Surgery Institute of Gansu...
LanZhou University; Beijing 302 Hospital; Beijing Shijitan Hospital, Capital... and other collaborators

Completed

Timing of Endoscopy for Acute Variceal Bleeding in Patients With Cirrhosis

Portal Hypertension | Cirrhosis, Liver | Varice Bleed

China
Fujian Cancer Hospital
Hunan Cancer Hospital; Wuhan TongJi Hospital

Not yet recruiting

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Small Cell Lung Cancer

China
Massachusetts General Hospital
M.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Dana-Farber...

Completed

Detecting EGFR T790M Mutations From Circulating Tumor Cells

Non Small Cell Lung Cancer

United States
Korea Cancer Center Hospital
Asan Medical Center; Seoul National University Hospital; Gangnam Severance Hospital

Recruiting

Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer (TACO)

Cervical Cancer

Korea, Republic of, China, Thailand, Vietnam
Saitama Medical University International Medical...
National Cancer Center, Japan; Tokyo University; Cancer Institute Hospital, Japan and other collaborators

Active, not recruiting

Pembrolizumab Plus Olaparib in Patients With Recurrent Cervical Cancer

Cervical Cancer

Japan
German Cancer Research Center
University Hospital Heidelberg; University Hospital Dresden

Not yet recruiting

Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients With AML (GALAXY33)

Relapsed/Refractory Acute Myeloid Leukemia (AML)

Germany
University Hospital Heidelberg
German Cancer Research Center; University Hospital Dresden

Active, not recruiting

OPPOSITE: Outcome Prediction Of Systemic Treatment in Esophagogastric Carcinoma (OPPOSITE)

Esophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric Neoplasm

Germany
University Hospital Heidelberg
German Cancer Research Center; University Hospital Dresden

Terminated

Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival (PERDAM)

Leukemia, Myeloid, Acute

Germany
Massachusetts General Hospital
M.D. Anderson Cancer Center; National Cancer Institute (NCI)

Active, not recruiting

High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull

Chordoma of Sacrum | Chordoma of Spine | Chordoma of Base of Skull | Chondrosarcoma of the Spine | Chondrosarcoma of the Sacrum

United States
Barretos Cancer Hospital
University of Campinas, Brazil; AC Camargo Cancer Center

Unknown

Metformin Plus Irinotecan for Refractory Colorectal Cancer

Adenocarcinoma | Colorectal Neoplasms

Brazil
Qilu Hospital of Shandong University
First Affiliated Hospital Xi'an Jiaotong University; First Affiliated Hospital... and other collaborators

Not yet recruiting

A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

Hepatitis B, Chronic
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Massachusetts General Hospital

Active, not recruiting

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

Esophageal Cancer

United States
Massachusetts General Hospital
M.D. Anderson Cancer Center; National Cancer Institute (NCI)

Active, not recruiting

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma

Brain Tumor | Medulloblastoma | Pineoblastoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Massachusetts General Hospital

Completed

Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)

Lung Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Adelphi University; Queen's Hospital Center

Completed

Measurement of Cancer-Related Risk Perception in Smokers

Survey | Risk Perception | Cancer Related-Risks | Focus Group

United States
Fujian Cancer Hospital

Not yet recruiting

Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI

Leptomeningeal Metastasis

China
Zhejiang Cancer Hospital

Recruiting

Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (Stars)

Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma

China
Zhejiang Cancer Hospital

Not yet recruiting

Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy

Gastric Cancer

China
Hubei Cancer Hospital

Not yet recruiting

SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer

Breast Cancer
Zhejiang Cancer Hospital

Recruiting

Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer

Non-Resectable Pancreas Carcinoma

China
Henan Cancer Hospital

Not yet recruiting

Serplulimab Plus Chemotherapy for Early-stage ER+/HER2- Breast Cancer

Breast Cancer

China
Zhejiang Cancer Hospital

Recruiting

Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma

HER2 Gene Mutation | Bile Duct Adenocarcinoma Non-Resectable

China
Zhejiang Cancer Hospital

Not yet recruiting

Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital

Recruiting

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Gastric Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Biliary Tract Cancer | Gastroesophageal Junction Adenocarcinoma | Liver Cancer Stage IV

China
Henan Cancer Hospital

Recruiting

Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer

Metastatic Gastroesophageal Junction Adenocarcinoma

China

Clinical Trials Sponsored by Linyi Cancer Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations